drugset / Trial / NCT01872013

Multiple Oral Administration of ASP7991 to Non-elderly Male Subjects

NCT01872013

Phase 1 Completed 36 enrolled Astellas Pharma Inc
RandomizedParallel-groupQuadruple-blind

Summary

This study is to assess the safety, tolerability, plasma concentration and pharmacodynamics of ASP7991 after multiple oral administrations to non-elderly subjects.

Timeline

Start
2012-11
Primary completion
2013-02
Completion
2013-02

Drugs

EvaluationDrugModalityDoseRoute
Subject ASP7991 Unknown Oral

Indications

No indication recorded.